Seminars in Hematology
Volume 47, Issue 1 , Pages 79-85 , January 2010

Transplant Outcomes for Primary Immunodeficiency Disease

  • Angela R. Smith

      Affiliations

    • Department of Pediatrics, University of Minnesota Pediatric Blood and Marrow Transplant Program, Minneapolis, MN
    • ,
  • Thomas G. Gross

      Affiliations

    • Department of Pediatrics, Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH
    • ,
  • K. Scott Baker

      Affiliations

    • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
    • Corresponding Author InformationAddress correspondence to K. Scott Baker, MD, Director, Survivorship Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Mailstop D5-280, Seattle, WA 98109-1024

References 

  1. Gatti R, Meuwissen H, Allen H, Hong R, Good R. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1366–1369
  2. Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci U S A. 1978;75:2933–2936
  3. Müller-Ruchholtz W, Wottge H, Müller-Hermelink H. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow. Transplant Proc. 1976;8:537–541
  4. Gennery A, Cant A. Cord blood stem cell transplantation in primary immune deficiencies. Curr Opin Allergy Clin Immunol. 2007;7:528–534
  5. Bach F, Albertini R, Joo P, Anderson J, Bortin M. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2:1364–1366
  6. Rimm I, Rappeport J. Bone marrow transplantation for the Wiskott-Aldrich syndrome (Long-term follow-up). Transplantation. 1990;50:617–620
  7. Mullen C, Anderson K, Blaese R. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood. 1993;82:2961–2966
  8. Fischer A, Friedrich W, Fasth A, Blanche S, Le Deist F, Girault D, et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood. 1991;77:249–256
  9. Rumelhart S, Trigg M, Horowitz S, Hong R. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome. Blood. 1990;75:1031–1035
  10. Inagaki J, Park Y, Kishimoto T, Yoshioka A. Successful unmanipulated haploidentical bone marrow transplantation from an HLA 2-locus-mismatched mother for Wiskott-Aldrich syndrome after unrelated cord blood stem cell transplantation. J Pediatr Hematol Oncol. 2005;27:229–231
  11. Brochstein J, Gillio A, Ruggiero M, Kernan N, Emanuel D, Laver J, et al. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. J Pediatr. 1991;119:907–912
  12. Filipovich A, Stone J, Tomany S, Ireland M, Kollman C, Pelz C, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598–1603
  13. Kobayashi R, Ariga T, Nonoyama S, Kanegane H, Tsuchiya S, Morio T, et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Haematol. 2006;135:362–366
  14. Pai S, DeMartiis D, Forino C, Cavagnini S, Lanfranchi A, Giliani S, et al. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant. 2006;38:671–679
  15. Kaneko M, Watanabe T, Watanabe H, Kimura M, Suzuya H, Okamoto Y, et al. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease. Int J Hematol. 2003;78:457–460
  16. Knutsen A, Steffen M, Wassmer K, Wall D. Umbilical cord blood transplantation in Wiskott Aldrich syndrome. J Pediatr. 2003;142:519–523
  17. Slatter M, Bhattacharya A, Flood T, Abinun M, Cant A, Gennery A. Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2006;47:332–334
  18. Buckley R, Schiff S, Sampson H, Schiff R, Markert M, Knutsen A, et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol. 1986;136:2398–2407
  19. Buckley R, Schiff S, Schiff R, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–516
  20. Friedrich W, Hönig M, Müller S. Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation. Immunol Res. 2007;38:165–173
  21. Grunebaum E, Mazzolari E, Porta F, Dallera D, Atkinson A, Reid B, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295:508–518
  22. Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113:4114–4124
  23. Antoine C, Müller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553–560
  24. Dalal I, Reid B, Doyle J, Freedman M, Calderwood S, Saunders F, et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant. 2000;25:613–621
  25. Filipovich A, Shapiro R, Ramsay N, Kim T, Blazar B, Kersey J, et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood. 1992;80:270–276
  26. Rao K, Amrolia P, Jones A, Cale C, Naik P, King D, et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood. 2005;105:879–885
  27. Bhattacharya A, Slatter M, Chapman C, Barge D, Jackson A, Flood T, et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant. 2005;36:295–299
  28. Díaz de Heredia C, Ortega J, Díaz M, Olivé T, Badell I, González-Vicent M, et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant. 2008;41:627–633
  29. Knutsen A, Wall D. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol. 2000;20:466–476
  30. Toren A, Nagler A, Amariglio N, Neumann Y, Golan H, Bilori B, et al. Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency. Bone Marrow Transplant. 1999;23:405–408
  31. Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant. 2006;37:469–477
  32. Ortega J, Rocha V, Wall D, Filipovich A, Bonfim C, Chan K, et al. Unrelated cord blood transplantation in children with primary immunodeficiencies. Bone Marrow Transplant. 2005;35:S57
  33. Henter J, Samuelsson-Horne A, Aricò M, Egeler R, Elinder G, Filipovich A, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367–2373
  34. Baker K, Filipovich A, Gross T, Grossman W, Hale G, Hayashi R, et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2008;42:175–180
  35. Baker K, DeLaat C, Steinbuch M, Gross T, Shapiro R, Loechelt B, et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood. 1997;89:3857–3863
  36. Cooper N, Rao K, Goulden N, Webb D, Amrolia P, Veys P. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant. 2008;42:S47–S50
  37. Minegishi M, Ohashi Y, Kumaki S, Sasahara Y, Hayashi T, Asada H, et al. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2001;27:883–886
  38. Schwinger W, Urban C, Lackner H, Benesch M, Kerbl R, Dornbusch H, et al. Unrelated 5/6-locus matched umbilical cord blood transplantation in a 23-month-old child with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 1998;22:393–396
  39. Bradley M, Satwani P, Baldinger L, Morris E, van de Ven C, Del Toro G, et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant. 2007;40:621–631
  40. Knutsen AP, Wall DA. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. J Allergy Clin Immunol. 1999;103:823–832
  41. Kuliev A, Rechitsky S, Tur-Kaspa I, Verlinsky Y. Preimplantation genetics: Improving access to stem cell therapy. Ann N Y Acad Sci. 2005;1054:223–227
  42. Verlinsky Y, Rechitsky S, Sharapova T, Morris R, Taranissi M, Kuliev A. Preimplantation HLA testing. JAMA. 2004;291:2079–2085
  43. Verlinsky Y, Rechitsky S, Sharapova T, Laziuk K, Barsky I, Verlinsky O, et al. Preimplantation diagnosis for immunodeficiencies. Reprod Biomed Online. 2007;14:214–223

PII: S0037-1963(09)00132-2

doi: 10.1053/j.seminhematol.2009.10.001

Seminars in Hematology
Volume 47, Issue 1 , Pages 79-85 , January 2010

Article Tools